ArticleACS chemical neuroscience2025
Fluorometric Nanoscale Analysis of Bilirubin and Biliverdin in Human Cerebrospinal Fluid.
Article in ACS chemical neuroscience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Predominance of Biliverdin over Bilirubin in Human Seminal Plasma.Biomolecules · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cerebrospinal fluid (CSF) is a valuable source for the quantification of soluble, brain-specific biomarkers supporting the diagnosis of some neurological disorders, infectious diseases, and suspected subarachnoid hemorrhage. Given the increasing need to expand the basic knowledge of brain pathophysiology for disease biomarker discovery, we set the goal to quantify bilirubin and biliverdin in human CSF. Their concentrations are expected to reflect the level of brain heme catabolism, a key pathway involved in the biological response to oxidative stress. Here, we present the results of the CSF analysis by a specific and sensitive fluorometric method using the recombinant fusion protein HELP-UnaG (HUG). The concentrations of bilirubin and biliverdin in 50 human CSF samples were in the ranges of 14-340 and 0-66 nM, respectively. This assay can be easily implemented in small-scale laboratories and neurological units for the routine analysis of clinical CSF samples.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.